The Boehringer Ingelheim Foundation honours particularly outstanding scientific achievements with its science awards. Endowed with 100,000 euros, the Heinrich Wieland Prize honours distinguished scientists from around the world for their groundbreaking research on biologically active molecules and systems in the fields of chemistry, biochemistry, and physiology, as well as their clinical importance. As of 2022, five of the Prize’s laureates have subsequently received the Nobel Prize.
The Foundation awards the Boehringer Ingelheim Prize to excellent and advanced early-career scientists at the University Medical Center of the University of Mainz. It has been presented annually since 1969 for excellence in clinical as well as theoretical medicine, and is endowed with a total of 30,000 euros in prize money.
Each year, the Foundation awards four PhD student prizes at the University of Mainz in recognition of particularly excellent dissertations or theses in biology, medicine, chemistry, and pharmacy.
2023 Heinrich Wieland Prize.
Professor Matthias Tschöp of Helmholtz Munich, Germany, receives the 2023 Heinrich Wieland Prize for his seminal discoveries of the first highly effective drugs to treat human obesity. He will be presented with the 100,000 euro prize during a festive award ceremony following a scientific symposium at Münchner Künstlerhaus in Munich, Germany, on 19 October 2023.
If you are interested in attending the event, you are cordially invited to register via the Heinrich Wieland Prize website. A limited number of travel grants are available for junior researchers to enable their participation.
2023 Boehringer Ingelheim Prize.
Dr Mandy Beyer and Dr Damian Herz, PhD, have been awarded this year's Boehringer Ingelheim Prize for their outstanding research work: Dr Beyer from the Institute of Toxicology developed an innovative therapeutic approach for the treatment of malignant leukemias. Dr Herz, PhD, from the Clinic and Polyclinic for Neurology discovered a new approach to improve deep brain stimulation for the treatment of Parkinson's disease. The Boehringer Ingelheim Prize is endowed with 30,000 euros and is equally divided between the two early-career researchers.
Please find the full press release here (in German language only)